O6-methylguanine-DNA methyltransferase and human cancer chemotherapy

J Environ Pathol Toxicol Oncol. 1993 Apr-Jun;12(2):73-80.

Abstract

Two kinds of human tumor cell strains having different activity of O6-methylguanine-DNA methyltransferase (O6-MT) were transplanted into nude mice. Mice were then injected intraperitoneally (i.p.) with the bifunctional agent 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride(ACNU). The tumors with low O6-MT activity were quickly suppressed or cured. This result suggests that some tumors, if determined to have low O6-MT activity, might be cured if the host is treated with ACNU. This observation may open a new approach to experimental cancer chemotherapy. Treatment with ACNU of experimental animals bearing HeLaMR tumors (which have low O6-MT activity and are Mer-), resulted in the regression of the tumors or their disappearance. In animals bearing HeLaS3 tumors (which have high O6-MT activity and are Mer+) the tumors were hyperplastic.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Carcinoma / drug therapy*
  • Carcinoma / enzymology
  • Carcinoma / pathology
  • Cell Division / drug effects
  • Female
  • HeLa Cells
  • Humans
  • Methyltransferases / metabolism*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Microscopy, Electron
  • Nimustine / administration & dosage*
  • O(6)-Methylguanine-DNA Methyltransferase
  • Uterine Cervical Neoplasms / drug therapy*
  • Uterine Cervical Neoplasms / enzymology
  • Uterine Cervical Neoplasms / pathology

Substances

  • Nimustine
  • Methyltransferases
  • O(6)-Methylguanine-DNA Methyltransferase